- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Steroid-Exacerbated Tinea Corporis
A pruritic lesion on the arm of a 26-year-old woman had grown to 22 cm while she was "treating" the eruption with a topical corticosteroid.
A pruritic lesion on the arm of a 26-year-old woman had grown to 22 cm while she was “treating” the eruption with a topical corticosteroid. Joe Monroe, PA-C, of Tulsa, Okla, suspected corticosteroid-exacerbated tinea corporis despite obfuscation of the annular border, which was caused by the lesion's unusually large size.
Tinea corporis was confirmed by a potassium hydroxide evaluation; the patient was advised to discontinue the topical corticosteroid immediately. In addition, a 7-day course of oral terbinafine, 250 mg bid, and application of antifungal cream as needed were prescribed. The dermatophytosis cleared after 1 month.
This patient was an elementary school teacher. It was thought that she acquired the infection from a child in her class.
